Market Analysts see Esperion Therapeutics Inc [ESPR] gaining to $2.50. Time to buy?
Esperion Therapeutics Inc [NASDAQ: ESPR] closed the trading session at $2.25. The stocks have a year to date performance of -24.75 percent and weekly performance of -35.34 percent. The stock has been moved at -24.75 percent over the last six months. The stock has performed